Skip to main navigation
Skip to search
Skip to main content
Northwestern Scholars Home
Help & FAQ
Home
Experts
Organizations
Research Output
Grants
Core Facilities
Research Data
Search by expertise, name or affiliation
NN9211-4083 The Efficacy and Safety of Liraglutide Adjunct to Insulin Treatment in Type 1 Diabetes: A 26 Weeks Radomised, Insulin Capped, Placebo-Controlled, Double-Blind, Parallel Group, Multinational, Multi-Centre Trial.
Aleppo, Grazia
(PD/PI)
Medicine, Endocrinology Division
Project
:
Research project
Overview
Project Details
Status
Finished
Effective start/end date
7/8/14
→
7/8/17
Funding
Novo Nordisk Inc.
(NN9211-4083)
View all
View less